These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 18448457)

  • 1. CD4+ T cell hyper-responsiveness in CD45 transgenic mice is independent of isoform.
    Salmond RJ; McNeill L; Holmes N; Alexander DR
    Int Immunol; 2008 Jul; 20(7):819-27. PubMed ID: 18448457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cell development in mice expressing splice variants of the protein tyrosine phosphatase CD45.
    Kozieradzki I; Kündig T; Kishihara K; Ong CJ; Chiu D; Wallace VA; Kawai K; Timms E; Ionescu J; Ohashi P; Marth JD; Mak TW; Penninger JM
    J Immunol; 1997 Apr; 158(7):3130-9. PubMed ID: 9120266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The differential regulation of Lck kinase phosphorylation sites by CD45 is critical for T cell receptor signaling responses.
    McNeill L; Salmond RJ; Cooper JC; Carret CK; Cassady-Cain RL; Roche-Molina M; Tandon P; Holmes N; Alexander DR
    Immunity; 2007 Sep; 27(3):425-37. PubMed ID: 17719247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consequences of increased CD45RA and RC isoforms for TCR signaling and peripheral T cell deficiency resulting from heterogeneous nuclear ribonucleoprotein L-like mutation.
    Wu Z; Yates AL; Hoyne GF; Goodnow CC
    J Immunol; 2010 Jul; 185(1):231-8. PubMed ID: 20505149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of CD45 isoforms correlates with differential proliferative responses of peripheral CD4+ and CD8+ T cells.
    Seki I; Suzuki M; Miyasaka N; Kohsaka H
    Immunol Lett; 2010 Mar; 129(1):39-46. PubMed ID: 20093141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD45 isoforms in T cell signalling and development.
    McNeill L; Cassady RL; Sarkardei S; Cooper JC; Morgan G; Alexander DR
    Immunol Lett; 2004 Mar; 92(1-2):125-34. PubMed ID: 15081536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative regulation of CD45 by differential homodimerization of the alternatively spliced isoforms.
    Xu Z; Weiss A
    Nat Immunol; 2002 Aug; 3(8):764-71. PubMed ID: 12134145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered CD45 isoform expression affects lymphocyte function in CD45 Tg mice.
    Tchilian EZ; Dawes R; Hyland L; Montoya M; Le Bon A; Borrow P; Hou S; Tough D; Beverley PC
    Int Immunol; 2004 Sep; 16(9):1323-32. PubMed ID: 15302847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical association of CD4 and CD45 in primary, resting CD4+ T cells.
    Bonnard M; Maroun CR; Julius M
    Cell Immunol; 1997 Jan; 175(1):1-11. PubMed ID: 9015182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of restricted isoform expression and tyrosine phosphatase activity of CD45 in murine dendritic cells.
    Haidl ID; Ng DH; Rothenberger S; Johnson P; Jefferies WA
    Eur J Immunol; 1995 Dec; 25(12):3370-4. PubMed ID: 8566025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD45 regulates apoptosis in peripheral T lymphocytes.
    Liu Z; Dawes R; Petrova S; Beverley PC; Tchilian EZ
    Int Immunol; 2006 Jun; 18(6):959-66. PubMed ID: 16621865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The phenotype and survival of antigen-stimulated transgenic CD4 T cells in vivo: the influence of persisting antigen.
    Yang CP; Sparshott SM; Duffy D; Garside P; Bell EB
    Int Immunol; 2006 Apr; 18(4):515-23. PubMed ID: 16481344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of T cells with differential responses to alloantigens in CD45 exon 6-deficient mice.
    Kong YY; Kishihara K; Yoshida H; Mak TW; Nomoto K
    J Immunol; 1995 Jun; 154(11):5725-35. PubMed ID: 7751624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in the level of CD45 surface expression affect the outcome of thymic selection.
    Wallace VA; Penninger JM; Kishihara K; Timms E; Shahinian A; Pircher H; Kündig TM; Ohashi PS; Mak TW
    J Immunol; 1997 Apr; 158(7):3205-14. PubMed ID: 9120275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CD45 tyrosine phosphatase: a positive and negative regulator of immune cell function.
    Alexander DR
    Semin Immunol; 2000 Aug; 12(4):349-59. PubMed ID: 10995582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential requirements of CD45 protein tyrosine phosphatase for cytolytic activities and intrathymic and extrathymic development of intestinal intraepithelial lymphocytes.
    Yada S; Kishihara K; Kong YY; Nomoto K
    J Immunol; 1998 Sep; 161(5):2208-16. PubMed ID: 9725213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tyrosine phosphatase CD45 is essential for coupling T-cell antigen receptor to the phosphatidyl inositol pathway.
    Koretzky GA; Picus J; Thomas ML; Weiss A
    Nature; 1990 Jul; 346(6279):66-8. PubMed ID: 2164155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PEST domain-enriched tyrosine phosphatase (PEP) regulation of effector/memory T cells.
    Hasegawa K; Martin F; Huang G; Tumas D; Diehl L; Chan AC
    Science; 2004 Jan; 303(5658):685-9. PubMed ID: 14752163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting CD45RB alters T cell migration and delays viral clearance.
    Lim B; Sutherland RM; Zhan Y; Deliyannis G; Brown LE; Lew AM
    Int Immunol; 2006 Feb; 18(2):291-300. PubMed ID: 16361310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered CD45 expression in C77G carriers influences immune function and outcome of hepatitis C infection.
    Dawes R; Hennig B; Irving W; Petrova S; Boxall S; Ward V; Wallace D; Macallan DC; Thursz M; Hill A; Bodmer W; Beverley PC; Tchilian EZ
    J Med Genet; 2006 Aug; 43(8):678-84. PubMed ID: 16505159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.